نتایج جستجو برای: cell transplantation

تعداد نتایج: 1769957  

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran kamran alimogaddam hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran mohammad jahani hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran amirali hamidieh hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran seyed asadollah mousavi hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran masoud iravani hematology- oncology and stem cell research center, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: this review reports the current results of hematopoietic stem cell transplantation (hsct) in patients who had received transplantation in the hematology-oncology and sct research center, tehran, iran. methods: in iran, from 1991 through 2010, a total of 3170 hematopoietic stem cell transplantation have been carried out. the male/female patient ratio was 1909/1261 with a median age...

Journal: :مجله علوم اعصاب شفای خاتم 0
yousef mohamadi department of anatomy, school of medicine, tehran university of medical sciences, tehran, iran maryam borhani-haghighi shefa neuroscience research center, khatam alanbia hospital, tehran, iran

cell therapy is known as one of the most promising curative interventions in the spinal cord injury (sci). selection of an appropriate route to transplant the stem cells is very important. principally, four different injection routes have been used in animal experiments. 1. intramedullary route: this route is known as a classic method for transplantation of stem cells. in this method, the stem ...

Journal: :acta medica iranica 0
parisa goodarzi clinical grade cell manufacturing facility, brain and spinal cord injury research center, tehran university of medical sciences, tehran, iran. babak arjmand clinical grade cell manufacturing facility, brain and spinal cord injury research center, tehran university of medical sciences, tehran, iran. and endocrinology and metabolism research center, endocrinology and metabolism research institute, tehran university of medical sciences. tehran, iran. seyed hassan emami-razavi clinical grade cell manufacturing facility, brain and spinal cord injury research center, tehran university of medical sciences, tehran, iran. masoud soleimani department of hematology, tarbiat modares university, tehran, iran. abbas khodadadi iranian tissue bank, research and preparation center, tehran university of medical sciences, tehran, iran. fereshteh mohamadi-jahani clinical grade cell manufacturing facility, brain and spinal cord injury research center, tehran university of medical sciences, tehran, iran.

nowadays, cell -based and tissue engineered products have opened new horizons in treatment of incurable nervous system disorders. the number of studies on the role of schwann cells (sc) in treating nervous disorders is higher than other cell types. different protocols have been suggested for isolation and expansion of sc which most of them have used multiple growth factors, mitogens and fetal b...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran amir ali hamidieh hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran mohammad jahani hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: allogeneic hematopoietic cell transplantation (hsct) is the only therapeutic modality capable of correcting the hematologic manifestations of fanconi anemia (fa). the development  of well  tolerated,  immunosuppressive  conditioning  regimens  for fa patients  undergoing hsct has proven to be a rather challenging task for hematologists. methods: we analyzed the outcome of 30 fa pa...

Journal: :iranian red crescent medical journal 0
ardeshir ghavamzadeh hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran kamran alimoghaddam hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran; hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran. email: fatemeh ghaffari hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran roshanak derakhshandeh hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran arash jalali hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran mohammad jahani hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran

conclusions in iran, hsct has been successfully adapted in routine clinical care. recently, new methods such as double cord blood and haploidentical transplantation have been used to treat many life-threatening diseases. results about 78.2% of the patients (2530 of 3237) remained alive between one to 211 months after stem cell transplantation. nearly, 21.8% (707) of our patients died after stem...

Journal: :بینا 0
علیرضا برادران رفیعی ar baradaran-rafie ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم مهدی اصلانی m aslani ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم حسین حسن پور h hasanpoor ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم مرجان زارع جوشقانی m zare joshaghani ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم حسین جمالی h jamali دانشگاه علوم پزشکی شیراز محمد زارع جوشقانی m zare joshaghani ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم بهرام عین الهی

purpose: to report the outcomes of conjunctival-limbal autograft (clau) in patients with unilateral total limbal stem cell deficiency (lscd) emphasizing surgical problems, complications, and their management. methods: in this prospective interventional case series, clau combined with amniotic membrane transplantation as a graft was performed on 26 patients with unilateral total lscd due to chem...

Journal: :iranian journal of public health 0
rowshanak abbasi bagher larijani ensieh nasli esfahani mostafa ghor­bani camelia rambod ramin heshmat

background: stem cell therapy is a new treatment option for different diseases. the aim of this systematic review is assessing the articles that focus on sct in iran and evaluate the amount of their success, failure and complication. methods: systematic search was conducted for finding english and persian papers (controlled trials and cohort studies with follow up) published before march 2015. ...

Journal: :international journal of hematology-oncology and stem cell research 0
mohammad vaezi hematology- oncology and stem cell transplantation research center, tehran university of medical sciences davoud oulad dameshghi qom university of medical sciences maryam souri hematology- oncology and stem cell transplantation research center, tehran university of medical sciences seyed amin setarehdan hematology- oncology and stem cell transplantation research center, tehran university of medical sciences kamran alimoghaddam hematology- oncology and stem cell transplantation research center, tehran university of medical sciences ardeshir ghavamzadeh hematology- oncology and stem cell transplantation research center, tehran university of medical sciences

the increased risk of hemolytic reactions and erythrocyte recovery delay in abo incompatible hematopoietic stem cell transplantation (hsct) is well established. effects of abo incompatibility on transplantation outcomes is evaluated in this study. we prospectively followed 501 patients undergoing allogeneic stem cell transplantation according to abo compatibility groups of minor, major and bidi...

Journal: :journal of skin and stem cell 0
sona zare skin and stem cell research center, tehran university of medical sciences, tehran, ir iran reza ahmadi department of clinical biochemistry, faculty of medicine, iran university of medical sciences, tehran, ir iran ayoob rostamzadeh department of anatomical sciences, faculty of medicine, shahrekord university of medical sciences, shahrekord, ir iran soleiman kurd school of advanced technologies in medicine, shahid beheshti university of medical sciences, tehran, ir iran somayeh hejazi skin and stem cell research center, tehran university of medical sciences, tehran, ir iran maryam fard department of anatomical science, faculty of medicine, qazvin university of medical sciences, qazvin, ir iran

context connective tissue cells include fibroblasts, chondrocytes, adipocyte, and osteocytes. these cells are specialized for the secretion of collagenous extracellular matrix and are responsible for the architectural framework of the human body. evidence acquisition connective tissue cells play a central role in supporting as well as repairing tissues and organs. fibroblast cell therapy could ...

Journal: :international journal of hematology-oncology and stem cell research 0
roghayeh hosseinikia 1. faculty of public health, kermanshah university of medical sciences, kermanshah, iran mohammad reza nikbakht 2. department of pharmacology, faculty of medicine, yasuj university of medical sciences , yasuj , iran ali asghar moghadam 3. college of veterinary medicine, razi university, kermanshah, iran ahmad tajehmiri 4. medical biology research center, kermanshah university of medical sciences , kermanshah, iran mahboobe hosseinikia 5. faculty of public health, kermanshah university of medical sciences, kermanshah, iran farhad oubari 6.medical biology research center, kermanshah university of medical sciences , kermanshah, iran

mesenchymal stem cells (mscs),as the major stem cells for cell therapy, have been studied from different aspects in pre-clinical and clinical settings for more than a decade. these cells modulate the immune system (humoral and cellular immune responses) in vitro by producing soluble factors (anti-inflammatory molecules) and/or making cell-cell contacts. hence they could be used in regenerative ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید